China Pharma, through its subsidiary, Hainan Helpson Bio-pharmaceutical Co., Ltd, is a specialty pharmaceutical company that develops, manufactures and markets generic and brand pharmaceutical products for both western and traditional Chinese medicines in China. Currently, the company¨s main focus for its therapeutics includes CNS, cardiovascular, cerebrovascular, wound recovery, digestive disease, and infectious diseases. Its products are sold in 30 provinces, municipalities, and autonomous regions. The Company has 16 sales offices and approximately 680 proxy agents in the whole country.
China Pharma is located in the tax-free industrial zone of Haikou, Hainan Province, with manufacturing facility of 8,000 square meters. The Company is equipped with eight GMP(Good Manufacturing Practice) certified production lines and has the capacity to produce drugs in a variety of delivery mechanisms including freeze dried(lyophilized injectables), capsules, tablets, granules, injectables, and oral fluids(suspension). The company is positioning itself to benefit from China¨s rapidly growing pharmaceutical market as it expands its product portfolio.
In Sep., 2009, China Pharma began trading on NYSE Amex, under the stock ticker of CPHI.